Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights 2021-08-26 19:56
RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S. 2021-02-23 20:33
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease 2021-01-06 20:24
1